ModernMedicine Resource Center More Topics

Video

Combination therapy seems best for relief of psoriasis

Combination therapy seems best for relief of psoriasis. Learn about which therapies work in the best combinations for your psoriasis patients.

Treatments for Plaque Psoriasis

Risankizumab outperforms ustekinumab in psoriasis trial
Risankizumab outperforms ustekinumab in psoriasis trialThe IL-23 inhibitor risankizumab was superior to ustekinumab in a phase two trial of adult patients with moderate-to-severe chronic plaque psoriasis, researchers report.
Psoriasis duration linked to cardiovascular disease riskNew research offers strong evidence that vascular inflammation and risk of having a major adverse cardiovascular event increases with psoriasis duration.
New psoriasis patient profileMetabolomics could provide new statistical methods to help monitor psoriasis disease and progression.
Biologic risk tolerance differs for pregnant patientsOf several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, not all have the same safety profile during pregnancy and lactation periods.
Expense drivers for costliest psoriasis patientsFindings of a recent study challenge the notion that psoriasis patients may be generally healthy and only occur expenses related to their medications or psoriasis.
Dermatologists collaborate on data-driven pediatric psoriasis researchA global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes
Earlier diagnosis of psoriatic arthritis will prevent disease progression
Earlier diagnosis of psoriatic arthritis will prevent disease progressionPsoriatic arthritis can often go undiagnosed in patients with psoriasis, and an earlier diagnosis is critical to prevent the adverse effects of psoriatic arthritis, according to an expert.
Abatacept: Pricey, but Effective
Abatacept: Pricey, but EffectiveThe approval of abatacept (Orencia/Bristol-Myers Squibb) for psoriatic arthritis (PsA) earlier this month by the FDA offers a new treatment option for patients who are struggling to keep the disease under control.
Future technology could make psoriasis pills, injections obsoleteA novel cell-based strategy tested in mice can detect the onset of psoriasis flares by measuring disease biomarkers and then release therapeutic proteins to stop progression. Future implications are exciting.
What looks promising in the pipeline for psoriasisAs research advances understanding of psoriasis, drug development evolves to address various pathways to disease. A number of possibilities, now in clinical trials, appear safe, effective and promising with improved long-term clearance rates.